Acute Hemolytic Transfusion Reaction (ABO Incompatibility and Acute Serologic Incompatibility)

An acute hemolytic transfusion reaction is the rapid immune-mediated destruction of transfused red blood cells, most dangerously when group-incompatible (typically ABO-incompatible) blood is given. Recipient antibodies bind donor red cell antigens and activate complement, causing intravascular hemolysis that can present within minutes and, in severe cases, lead to shock, disseminated intravascular coagulation, and acute kidney injury. It is the prototypical immediate, immune transfusion reaction and a sentinel event in transfusion safety.

Definition

An acute hemolytic transfusion reaction is the destruction of transfused red cells within approximately 24 hours of transfusion caused by recipient antibodies reacting with donor red cell antigens, classically complement-fixing anti-A or anti-B in ABO-incompatible transfusion, producing intravascular hemolysis.

Scope

This entry covers the immunologic mechanism of acute hemolysis, the central role of ABO incompatibility (most often resulting from clerical or identification error), the laboratory features that distinguish it from other reactions, and its place among the most serious transfusion hazards. It is a reference description of the entity and its pathophysiology, not a protocol for diagnosis or management.

Key concepts

• ABO incompatibility
• Complement activation and intravascular hemolysis
• Free hemoglobin and hemoglobinuria
• Disseminated intravascular coagulation
• Acute kidney injury
• Clerical and patient-identification error
• Positive direct antiglobulin test
• Sentinel event in transfusion safety

Mechanisms

When red cells bearing an antigen are transfused into a recipient with pre-formed, complement-fixing antibody to that antigen — paradigmatically anti-A or anti-B against an ABO-incompatible unit — the antibody binds the donor cells and activates the complement cascade to completion, lysing the cells within the circulation. Released free hemoglobin and red cell stroma, together with cytokine and coagulation activation, drive hypotension, disseminated intravascular coagulation, and renal injury. Because naturally occurring ABO antibodies are present in all immunocompetent individuals, ABO-incompatible transfusion is uniquely hazardous, and most events stem from misidentification of the patient or sample rather than laboratory failure. Strobel reviews the serologic and clinical features, and Delaney and colleagues situate the reaction among acute transfusion events.

Clinical relevance

Acute hemolytic reactions are a principal reason that patient and sample identification and pretransfusion compatibility testing are treated as critical safety steps. This entry explains the mechanism and laboratory correlates as reference material; it does not provide diagnostic criteria, monitoring parameters, or treatment guidance for individual patients.

Epidemiology

Fatal ABO-incompatible reactions are rare but consistently appear among the leading immune causes of transfusion-related death in hemovigilance data, and they are largely preventable because they arise predominantly from identification errors. Vamvakas and Blajchman discuss hemolytic reactions among the major causes of transfusion-related mortality, and SHOT reporting (Bolton-Maggs and Cohen) documents incorrect-blood-component-transfused errors as a recurring source of such events.

History

The hazard of incompatible transfusion became understandable only after Karl Landsteiner's description of the ABO blood groups at the turn of the twentieth century, which explained why some transfusions caused catastrophic hemolysis. The subsequent development of blood grouping and compatibility testing transformed transfusion from a frequently fatal procedure into a routine one, and the persistence of ABO-incompatible reactions as identification errors has driven decades of work on transfusion safety systems.

Seminal works

• delaney-2016
• strobel-2008
• vamvakas-blajchman-2009

Frequently asked questions

Why is ABO incompatibility especially dangerous?

All immunocompetent people carry naturally occurring, complement-fixing anti-A and/or anti-B antibodies, so transfusing ABO-incompatible red cells triggers rapid intravascular hemolysis even on a first exposure, unlike most other red cell antigens that require prior sensitization.

What is the usual underlying cause of an acute hemolytic transfusion reaction?

Most severe ABO-incompatible events result from clerical or patient-identification errors — such as mislabeling a sample or transfusing a unit to the wrong patient — rather than from failures of laboratory testing.